A detailed history of Financial Gravity Asset Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 227 shares of ABBV stock, worth $39,877. This represents 0.01% of its overall portfolio holdings.

Number of Shares
227
Previous 227 -0.0%
Holding current value
$39,877
Previous $35.2 Million 10.6%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 26, 2024

SELL
$159.82 - $182.1 $159 - $182
-1 Reduced 0.44%
227 $35.2 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $703,048 - $801,057
-4,399 Reduced 94.16%
273 $49.6 Million
Q4 2023

Jun 26, 2024

SELL
$137.6 - $154.97 $6,192 - $6,973
-45 Reduced 16.48%
228 $35.3 Million
Q3 2023

Nov 15, 2023

BUY
$133.59 - $154.65 $576,307 - $667,160
4,314 Added 1205.03%
4,672 $696,000
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $662 - $824
-5 Reduced 1.38%
358 $6.71 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $29,066 - $33,474
201 Added 124.07%
363 $774,000
Q4 2022

Feb 15, 2023

SELL
$138.31 - $165.87 $422,398 - $506,566
-3,054 Reduced 94.96%
162 $7.68 Million
Q3 2022

Nov 03, 2022

SELL
$134.21 - $153.93 $102,268 - $117,294
-762 Reduced 19.16%
3,216 $2.76 Million
Q2 2022

Aug 05, 2022

SELL
$137.62 - $174.96 $32,203 - $40,940
-234 Reduced 5.56%
3,978 $3.17 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $520,265 - $645,502
3,942 Added 1460.0%
4,212 $3.52 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $28,791 - $36,429
268 Added 13400.0%
270 $224,000
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $102 - $112
-1 Reduced 33.33%
2 $212,000
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $241 - $326
3 New
3 $0
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $26,486 - $35,442
-361 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $258 - $391
4 Added 1.12%
361 $27,000
Q4 2019

Feb 28, 2020

SELL
$72.13 - $90.25 $3,606 - $4,512
-50 Reduced 12.29%
357 $121,000
Q3 2019

Oct 15, 2019

SELL
$62.98 - $75.72 $6,046 - $7,269
-96 Reduced 19.09%
407 $31,000
Q2 2019

Jul 26, 2019

BUY
$65.7 - $83.98 $14,979 - $19,147
228 Added 82.91%
503 $37,000
Q1 2019

Apr 19, 2019

SELL
$77.14 - $90.79 $325,145 - $382,679
-4,215 Reduced 93.88%
275 $22,000
Q3 2018

Oct 31, 2018

BUY
$88.91 - $98.84 $37,964 - $42,204
427 Added 10.51%
4,490 $365,000
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $10,234 - $12,110
114 Added 2.89%
4,063 $389,000
Q1 2018

May 23, 2018

BUY
$92.01 - $123.21 $363,347 - $486,556
3,949 New
3,949 $396,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $311B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.